Wound Dehiscence after Posterior Sagittal Anorectoplasty in Children with Anorectal Malformations
Table 1
Patients with ARM reconstructed with PSARP, limited PSARP, or PSARVUP.
All patients
Multistaged reconstruction
Single-staged reconstruction
P value∗
Total
90 (100)
50 (56)
40 (44)
Gender
Male
53 (59)
31 (62)
22 (55)
0.53
Female
37 (41)
19 (38)
18 (45)
ARM subtype
Perineal (M/F)
24 (45) / 17 (46)
3 (6)
38 (94)
Vestibular
15 (41% of F)
14 (28)
1 (3)
Rectourethral
20 (38% of M)
19 (38)
1 (3)
Rectovesical
4 (8% of M)
4 (8)
0
Cloaca
4 (11% of F)
4 (8)
0
No fistula (M/F)
5 (9) / 1 (2)
6 (12)
0
Prematurity n=77∗∗∗
15 (19)
11 (24)
4 (13)
0.25
SGA n=80∗∗∗
23 (29)
16 (33)
7 (22)
0.32
Concomitant malformations
Total (at least one)
63 (70)
44 (88)
19 (48)
<0.001
Cardiac n=84∗∗∗
28 (33)
18 (38)
10 (36)
0.48
Urinary tract n=85∗∗∗
25 (29)
20 (42)
5 (14)
0.008
Other skeletal
19 (21)
14 (28)
5 (13)
0.12
Vertebral n=60∗∗∗
30 (50)
25 (64)
5 (24)
0.003
Spinal cord n=47∗∗∗
14 (30)
10 (29)
4 (31)
0.93
Genital
17 (19)
14 (28)
3 (8)
0.015
Gastrointestinal tract
12 (13)
9 (18)
3 (8)
0.21
VACTERL association
24 (27)
19 (38)
5 (13)
0.008
Concomitant syndromes
Total
15 (17)
10 (20)
5 (13)
0.40
Trisomy 21
6 (7)
5 (10)
1 (3)
0.22
Age at PSARP (days)
122 (8–1234)
2 (0-616)
<0.001∗∗
Weight at PSARP (g) n=62∗∗∗
5700 (3100–14000)
3500 (1600–11400)
<0.001∗∗
Antibiotic prophylaxis > 1 day
33 (37)
19 (38)
14 (35)
0.83
Values presented as the absolute number and percentage of patients, n (%), and as median (min–max); ARM: anorectal malformations, PSARP: posterior sagittal anorectoplasty, PSARVUP: posterior sagittal anorectal vaginal urethroplasty; M: male, F: female; Prematurity: GW< 37; SGA: small for gestational age; ∗Fisher’s Exact test two-tailed, ∗∗Mann Whitney U-test two-tailed; ∗∗∗number of patients with available data
